Eczema News and Research

Latest Eczema News and Research

Exposure to cats early in life may raise childs' risk of eczema

According to new study in the U.S. children who are exposed to cats soon after birth may have an increased risk of developing eczema, while being exposed to two or more dogs at home may offer some slight protection.

23 May 2006

Using probiotics is a safe and effective way to prevent asthma in children

In the first effort of its kind in the United States, researchers at the University of California, San Francisco have launched a study to determine whether giving active probiotic supplements to infants can delay or prevent asthma in children.

17 May 2006

Extension of embryo screening will help reduce serious illness

A fertility watchdog in Britain, the Human Fertilisation and Embryology Authority (HFEA), has given approval for the extension of embryo screening to cover a wider range of mutated genes, in the main those which raise the risk of cancer in later life.

11 May 2006

Inhaled corticosteroids can reduce breathing problems in children at high risk for asthma

Studies in older children and adults show that the most effective long-term control medicine for persistent asthma (symptoms more than two days a week or more than twice a month at night) is inhaled corticosteroids, which reduce airway swelling and help prevent asthma symptoms (e.g., asthma attacks).

10 May 2006

217 new targets for anti-cancer drugs

By identifying novel genes critical to cancer progression, biologists at the U.S. Department of Energy's Argonne National Laboratory have expanded the number of drug targets researchers have available for study to find ways to stop tumors in their tracks.

18 Apr 2006

Fish enzymes and gelatine may be the new treatment for psoriasis and eczema

A new skin cream has shown promising results in the treatment of psoriasis and eczema. The cream contains fish enzymes and gelatine and is under development by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim and the University of Bergen, Norway.

23 Mar 2006

Immune system protein LL-37 critical in controlling replication of vaccinia virus

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have identified a defect in the immune response of people with the skin condition atopic dermatitis that puts them at risk of developing serious complications following smallpox vaccination.

23 Mar 2006

Potential therapeutic targets against serious side effects of smallpox vaccine

Smallpox is considered a potential terrorist weapon, but millions of people in the United States are currently advised not to get a vaccine to the disease because they are susceptible to developing a severe adverse reaction.

23 Mar 2006

Gene discovered that causes dry skin and leads to eczema and asthma

Experts, lead by the University of Dundee, have discovered the gene which causes genetic skin conditions affecting millions of people.

21 Mar 2006

Hand eczema caused by soaps in the workplace may lead to unemployment or prolonged sick leaves

Hand eczema caused by soaps and other irritants in the workplace may lead to unemployment or prolonged sick leaves from work for some individuals, according to an article in the March issue of Archives of Dermatology.

21 Mar 2006

Researchers to investigate links between asthma and genes

Professor Bill Cookson and Dr Miriam Moffatt, formerly at the University of Oxford, have joined Imperial's National Heart and Lung Institute to further develop the genetic research there, particularly focusing on how genes influence the development of asthma.

14 Mar 2006

Study shows new atopic dermatitis therapy significantly delays onset of flares

Stiefel Laboratories, the world's largest independent pharmaceutical company specializing in dermatology, announced that a recent study shows MimyX Cream extends the remission period of atopic dermatitis (AD) by 48 percent when used in conjunction with an emollient compared to emollient alone.

6 Mar 2006

American Academy of Dermatology disagrees with eczema medication action taken by FDA

The American Academy of Dermatology (Academy) has issued a statement in response to the U.S. Food and Drug Administration’s (FDA) announcement that a black box warning will be added to the labeling and a medication guide will be distributed for the topical calcineurin inhibitors (TCIs), pimecrolimus and tacrolimus.

23 Jan 2006

Black box warnings for two eczema creams

Food and Drug Administration officials in the U.S. have announced that two prescription creams to treat eczema will now carry strong warnings about the possible risk of skin cancer, lymphoma and other cancers.

22 Jan 2006

Anthroposophic lifestyle reduces the risk of allergic disease in children

Certain features of the anthroposophic lifestyle, such as restrictive use of antibiotics and fever antipyretics, reduce the risk of allergic disease in children, according to a new study.

10 Jan 2006

Botox - other applications

While botulinum toxin A, or BTXA, is widely known for its use in dermatology and aesthetic medicine, a review article in the Journal of Cosmetic Dermatology explores the drug’s other successful applications.

12 Dec 2005

Researchers identify gene defect in mice that causes cyclical hair loss and skin cancer

Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.

4 Oct 2005

Pharmacists can drastically reduce patients worries about using steroids

For those people who suffer from eczema, the use of topical corticosteroids is high up on their list of concerns: How should they be used? And are they safe?

26 Sep 2005

More than fifty percent of the U.S. population tested positive to one or more allergens

The new findings, based on data from the third National Health and Nutrition Examination Survey (NHANES III), shows that 54.3% of individuals aged 6-59 years old had a positive skin test response to at least one of the 10 allergens tested.

4 Aug 2005

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Glioblastoma multiforme (GBM) affects three out of 100,000 people, a rate that quadruples to 13 out 100,000 among people who are 65 and older. The average five-year survival rate from the time of diagnosis for GBM is only 3.3 percent, and is lower for people 65 and older.

15 Jul 2005

Eczema News and Research

Latest Eczema News and Research

Exposure to cats early in life may raise childs' risk of eczema

Using probiotics is a safe and effective way to prevent asthma in children

Extension of embryo screening will help reduce serious illness

Inhaled corticosteroids can reduce breathing problems in children at high risk for asthma

217 new targets for anti-cancer drugs

Fish enzymes and gelatine may be the new treatment for psoriasis and eczema

Immune system protein LL-37 critical in controlling replication of vaccinia virus

Potential therapeutic targets against serious side effects of smallpox vaccine

Gene discovered that causes dry skin and leads to eczema and asthma

Hand eczema caused by soaps in the workplace may lead to unemployment or prolonged sick leaves

Researchers to investigate links between asthma and genes

Study shows new atopic dermatitis therapy significantly delays onset of flares

American Academy of Dermatology disagrees with eczema medication action taken by FDA

Black box warnings for two eczema creams

Anthroposophic lifestyle reduces the risk of allergic disease in children

Botox - other applications

Researchers identify gene defect in mice that causes cyclical hair loss and skin cancer

Pharmacists can drastically reduce patients worries about using steroids

More than fifty percent of the U.S. population tested positive to one or more allergens

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Eczema News and Research

Latest Eczema News and Research

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Newsletters you may be interested in